US2017202920A1PendingUtilityA1

Compositions and Methods for Treating Rotator Cuff Injuries

53
Assignee: BIOMIMETIC THERAPEUTICS LLCPriority: Jun 30, 2006Filed: Mar 31, 2017Published: Jul 20, 2017
Est. expiryJun 30, 2026(expired)· nominal 20-yr term from priority
A61P 21/00A61L 27/227A61F 2/0811A61F 2002/0858A61B 2017/044A61L 2300/414A61L 27/54A61L 27/12A61L 2430/10A61B 2017/0464A61K 38/1858A61L 27/24A61F 2002/0876A61B 17/0401
53
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides compositions and methods for attaching tendon to bone. The present invention provides compositions and methods for treating rotator cuff injuries. In one embodiment, a method for treating rotator cuff injuries comprises providing a composition comprising PDGF disposed in a biocompatible matrix and applying the composition to at least one site of tendon reattachment on the humeral head.

Claims

exact text as granted — not AI-modified
1 . A method for attaching a tendon to a bone comprising:
 providing a composition comprising a PDGF solution disposed in a biocompatible matrix; and   applying the composition to at least one site of tendon reattachment on the bone.   
     
     
         2 . A method for treating rotator cuff tears comprising:
 providing a composition comprising a PDGF solution disposed in a biocompatible matrix; and   applying the composition to at least one site of tendon reattachment on the humeral head.   
     
     
         3 . The method of  claim 2 , wherein the at least one site of tendon attachment comprises a channel in cortical bone of the humeral head. 
     
     
         4 . The method of  claim 3 , wherein the channel comprises a size and a shape that corresponds to a tendon attachment footprint. 
     
     
         5 . The method of  claim 2 , further comprising disposing at least one bone anchor in the humeral head and coupling at least one detached tendon to the bone anchor. 
     
     
         6 . The method of  claim 5 , wherein the at least one bone anchor comprises the PDGF solution disposed in the biocompatible matrix. 
     
     
         7 . The method of  claim 5 , wherein the at least one tendon is coupled to the at least one bone anchor through at least one suture. 
     
     
         8 . The method of  claim 5 , wherein disposing at least one bone anchor in the humeral head comprises drilling at least one hole in the humeral head. 
     
     
         9 . The method of  claim 2 , further comprising molding the composition to contours of the tendon reattachment site. 
     
     
         10 . The method of  claim 2 , wherein applying the composition comprises injecting the composition at the tendon reattachment site. 
     
     
         11 . A method of treating a tendon comprising:
 providing a composition comprising a PDGF solution disposed in a biocompatible matrix; and   applying the composition to a surface of at least one tendon.   
     
     
         12 . The method of  claim 11 , wherein the at least one tendon has tearing, delamination, strain, or combinations thereof. 
     
     
         13 . The method of  claim 11 , wherein the biocompatible matrix comprises a scaffolding material. 
     
     
         14 . The method of  claim 13 , wherein the scaffolding material comprises β-tricalcium phosphate. 
     
     
         15 . The method of  claim 13 , wherein the scaffolding material comprises a collagen patch. 
     
     
         16 . The method of  claim 13 , wherein the PDGF solution has a concentration of PDGF ranging from about 0.01 mg/ml to about 10 mg/ml. 
     
     
         17 . The method of  claim 13 , wherein the PDGF solution has a concentration of PDGF ranging from about 0.1 mg/ml to about 0.3 mg/ml. 
     
     
         18 . A method of strengthening the attachment of a tendon to bone comprising:
 providing a composition comprising a PDGF solution disposed in a biocompatible matrix; and   applying the composition to a site of tendon attachment to bone.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.